- The Cure from CRISPR Classroom
- Posts
- Myotic Dystrophy Treatment Breakthrough
Myotic Dystrophy Treatment Breakthrough
PLUS: Mysteries Surround Ehlers-Danlos Syndrome
Hi friends 👋🏼,
From cancer to blindness - gene therapy is revolutionizing medicine. We’ve got four stories for you this week, taking three of your requests:
Myotic Dystrophy Treatment Breakthrough READER REQUEST
Mysteries Surround Ehlers-Danlos Syndrome READER REQUEST
Measles to Kill Medulloblastoma READER REQUEST
Let There Be Light: Gene Therapy for Blindness
Upgrade to Premium for access to weekly articles and to make custom requests from our team of scientists.
✋🏼🤚🏼 Myotonic Dystrophy Treatment Breakthrough
Congenital Myotonic Dystrophy (CMD) is an inherited genetic disorder characterized by progressive muscle wasting and weakness, among other symptoms. For example, imagine opening a door and having difficulty releasing your grip on the doorknob.
1/ CMD is caused by a mutated DMPK gene. Specifically, sections of the DMPK gene are incorrectly repeated thousands of times. As a result, the abnormally large gene produces an unusually large mRNA, producing a nonfunctional protein that causes the disease.
2/ Avidity Biosciences has developed AOC 1001, designed to address CMD's root cause.
Here’s how AOC 1001 works👇🏼
Subscribe to Premium to read the rest.
Become a paying subscriber of Premium to get access to this post and other subscriber-only content.
Already a paying subscriber? Sign In.
A subscription gets you:
- • Submit your disease request and we'll find and report on clinical trials, emerging medical technology, and innovative therapeutics.
- • Easy to understand science written for the everyday person.
- • Articles delivered to your inbox every Sunday.
- • Plus - No ads. Ever.